Temperature Sensitive Healthcare Products to Grow Robustly in the Coming Years

The share of temperature sensitive healthcare products in the global healthcare market is expected to reach 23% by 2017.
Spread the Word
Listed Under

* Biopharmaceuticals
* Healthcare Cold Chain
* Vaccine

* Biotech
* Health

* New Delhi - Delhi - India

* Products

Nov. 21, 2012 - PRLog -- The sluggish economic scenario is straining global trade and logistics, but there are still certain areas whose growing demand is currently defying this trend. The global market for healthcare cold chain logistic services is one such area which continues to grow at a robust pace. According to a recent report from IMARC Group titled “Global Healthcare Cold Chain Logistics Market Report & Forecast: 2012 – 2017”, the global market for products having cold chain requirements (biopharmaceuticals, vaccines and clinical trial materials) is currently growing rapidly. Findings from the report suggest that products having cold chain requirements currently account for 21% of the total global healthcare products market and by 2017 this share is expected to increase to around 23%.

According to an analyst from IMARC Group “The rising demand for biologics, vaccines and clinical trial materials means a potential business worth hundreds of billions of dollars, but it also means a huge need for reliable and efficient cold chain logistic services that can protect quality and efficacy of temperature sensitive healthcare products.” The report also suggests that regulatory agencies around the world have increased their scrutiny to ensure the integrity of healthcare products in the distribution chain.

The report, an updated and far more analytical version of our popular 2011 study, expects the total market for healthcare cold chain logistic services to grow robustly in the coming years. The study, that has been undertaken using both desk based and qualitative primary market research, has analyzed three aspects of the global healthcare cold chain logistics market.

The first aspect involves the quantification of the global market for temperature sensitive healthcare products into three major classes and evaluation of the current and future opportunities in each of these classes. The second aspect involves an in-depth understanding on the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products. The third aspect involves the quantification of the global healthcare cold chain logistic services market and a comprehensive evaluation of its various segments.

To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America
Email:  america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Phone: +44-702-409-7331

To know more please visit: http://www.imarcgroup.com/global-healthcare-cold-chain-lo...
Email:***@imarcgroup.com Email Verified
Tags:Biopharmaceuticals, Healthcare Cold Chain, Vaccine
Industry:Biotech, Health
Location:New Delhi - Delhi - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
IMARC Group News
Daily News
Weekly News

Like PRLog?
Click to Share